Trovagene Inc (TROV) 8.58 $TROV Interesting TROV Put And

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Trovagene Inc (TROV) 8.58 $TROV

Interesting TROV Put And Call Options For June 19th
StockOptionsChannel.com - Wed Apr 22, 10:23AM CDT
Investors in TrovaGene Inc saw new options begin trading this week, for the June 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TROV options chain for the new June 19th contracts and identified one put...
TROV: 8.58 (-0.27)

TrovaGene (TROV) Strong On High Relative Volume Today
at The Street - Tue Apr 21, 9:06AM CDT
Trade-Ideas LLC identified TrovaGene (TROV) as a strong on high relative volume candidate
TROV: 8.58 (-0.27)

TrovaGene's (TROV) PCM Data Impresses, Shares Rally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 20, 2:08PM CDT
Shares of TrovaGene Inc. (TROV) surged 20.14% to close at $8.53 on Apr 17, after the company reported favorable clinical data for its Precision Cancer Monitoring (PCM) technology.
TROV: 8.58 (-0.27), ANIP: 69.79 (+1.24), AVEO: 2.04 (+0.12), AMGN: 169.10 (+0.64)

Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research
PR Newswire - Mon Apr 20, 7:35AM CDT
In the search for neuroscience drug discovery treatments, Alzheimer's disease and specifically autism drug candidates, a few viable therapeutic approaches have come from research on neurological conditions such as fragile X syndrome. Biotech Companies in focus today are Neurotrope, Inc. (OTC: NTRP), CytRx Corporation (NASDAQ: CYTR), Trovagene, Inc., (NASDAQ: TROV), Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Abbot Laboratories (NYSE: ABT) & Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX).
ABT: 48.35 (+1.23), LXRX: 1.06 (-0.01), TROV: 8.58 (-0.27), CYTR: 5.21 (-0.06), BMY: 66.60 (-0.21), ARNA: 4.47 (+0.01)

Poster Presentations at 2015 AACR Annual Meeting to Highlight Clinical Utilities and Advantages of Trovagene's ctDNA Precision Cancer Monitoring Platform
PR Newswire - Mon Apr 20, 7:00AM CDT
Trovagene, Inc., (NASDAQ: TROV) a developer of cell-free molecular diagnostics, announced today that clinical and analytical data for the Company's Precision Cancer MonitoringSM platform will be presented at the American Association for Cancer Research Annual Meeting in Philadelphia. The data will be presented during the Circulating Free DNA Poster Session from 8 a.m. to noon EDT on April 22. Clinical study results include data for quantitatively monitoring KRAS mutations in pancreatic cancer patients and monitoring for minimal residual disease in metastatic colorectal cancer patients in the adjuvant (post-surgical) setting using liquid biopsy. Analytical results will be presented by the Company, which will include sensitivity data for its CLIA-available assays and the potential advantages of using urine samples to monitor cancer.
TROV: 8.58 (-0.27)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Apr 17, 11:45AM CDT

SPPR: 2.55 (-0.16), FNRG: 3.11 (-0.86), TROV: 8.58 (-0.27), CHKE: 22.82 (-0.17), XPLR: 6.14 (-0.04), CHOP: 3.67 (-0.26), IPDN: 3.02 (+0.04), GNMK: 10.51 (-0.22), XBIT: 27.55 (+0.18), GBSN: 4.98 (+1.44), NOW: 77.72 (+0.22), CE: 65.75 (-0.19), AMD: 2.28 (-0.07), CYTR: 5.21 (-0.06), TCPI: 3.85 (-0.13), PRO: 23.09 (-0.20), VIMC: 13.42 (+1.31), ATHX: 1.34 (+0.01), DSCO: 1.25 (unch), AWX: 3.65 (-0.02)

Trovagene's urine-based cancer monitoring platform beats biopsies; Shares jump 24%
Seeking Alpha - at Seeking Alpha - Fri Apr 17, 11:31AM CDT

TROV: 8.58 (-0.27)

Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients
PR Newswire - Fri Apr 17, 9:30AM CDT
Trovagene, Inc., (NASDAQ: TROV) a developer of cell-free molecular diagnostics, announced today that clinical data presented at the 2015 European Lung Cancer Conference (ELCC) demonstrate that its urine-based Precision Cancer Monitoringâ" (PCM) platform outperformed tissue biopsy for the detection and monitoring of EGFR T790M mutations in metastatic lung cancer patients. The abstract, titled Detection of EGFR T790M Mutation in Urinary Circulating Tumor DNA from Metastatic Non-Small Cell Lung Cancer Patients, was presented today by Hatim Husain, M.D., University of California, San Diego Moores Cancer Center during the ESMO-IASLC Best Abstracts session in Geneva, Switzerland.
TROV: 8.58 (-0.27)

InsiderInsights.com Daily Round Up 4/6/15: TROV, MRD, VBFC, IHRT
InsiderInsights - at Seeking Alpha - Tue Apr 07, 7:48AM CDT

ARCW: 7.06 (-0.57), TROV: 8.58 (-0.27), FB: 84.63 (+1.01), GIII: 116.32 (-1.15), MRD: 19.19 (+0.06), ABDC: 13.70 (-0.19), MFRM: 63.45 (-0.24), DSW: 36.68 (+0.08), JLL: 164.33 (+1.11), VBFC: 19.86 (-0.12), WIW: 11.45 (unch), AYN: 14.05 (-0.01), COST: 146.98 (-0.36), BLMN: 22.70 (unch), WIA: 11.60 (-0.04), CRM: 67.71 (+0.33), KPTI: 32.24 (-0.60)

New commercial chief at Trovagene
Seeking Alpha - at Seeking Alpha - Wed Mar 18, 11:14AM CDT

TROV: 8.58 (-0.27)

Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer
PR Newswire - Wed Mar 18, 7:31AM CDT
Trovagene, Inc., (NASDAQ: TROV) a developer of cell-free molecular diagnostics, announced today that Matthew L. Posard has joined the Company as executive vice president & chief commercial officer. Mr. Posard has more than 20 years of experience identifying, directing and successfully commercializing innovative technologies in the molecular diagnostic and life science fields. Most recently, he led the new and emerging market opportunities business at Illumina, Inc. (NASDAQ: ILMN).
HALO: 16.03 (+0.15), TROV: 8.58 (-0.27), ILMN: 190.04 (-9.27)

TrovaGene (TROV) Enters Overbought Territory
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Small Business Insurance Is a Costly Blind Spot Today

Updated Category News Views 32

A busted pipe, a fender-bender, or one bad fall can turn a promising little company into a very expensive regret. That is the plain-English value in insurance expert Michael Oehrke's overview for HelloNation: small-business insurance is not glamorous, it is not growth marketing, and it is often ignored until the owner is staring at a bill that can chew through years of...

Continue Reading
LevelTen Takes Its Clean-Power Market Model to India

Updated Category News Views 89

India's power market is not a tidy spreadsheet, thankfully. It is a vast, fast-growing grid where data centres, factories and climate exposure are all colliding with a generation mix still dominated by coal. That is why LevelTen Energy's move into Asia-Pacific deserves more than the usual clean-tech applause line. Beginning with a 500 MW clean-energy request for proposals...

Continue Reading
Vizsla's Panuco Delay Puts Security Ahead of Speed

Updated Category News Views 73

A mine schedule can absorb a calendar slip; the people around a mine cannot be treated like a line item. Vizsla Silver's update on Panuco is therefore not the usual development-company chest thumping. It is a sober admission that security, permitting and site readiness have pushed first silver to the second half of 2028, one year later than the prior H2 2027 target....

Continue Reading
Abbe Lane Estate Puts Jewelry Demand on Full Display

Updated Category News Views 40

Glamour Is Walking Back Into the Auction Room Abbe Lane’s jewelry is not being offered as a vague nostalgia exercise; it is arriving with dates, a setting, and a clear split between two December sales. John Moran Auctioneers will lead with The Estate of Abbe Lane on Wednesday, December 9, 2026, at 10:00 a.m. PST, then follow with its Jewelry & Watches auction on...

Continue Reading
Elijah Craig Uses AI Toasts to Sell a Warmer Pour

Updated Category News Views 129

A Speech Prompt With a Bourbon Label Few things expose holiday nerves faster than a raised glass and a room waiting for somebody to say something memorable. Elijah Craig has decided that awkward little moment is marketing territory, rolling out its Digital Perfect Pour, Perfect Toast Generator for mobile and desktop users ahead of the holiday season. The tool asks for a...

Continue Reading
Stanford Forum Puts Industrial AI in the Real World

Updated Category News Views 18

Factory Data Is Not a Free Lunch A factory dataset is worth precisely nothing if its owner cannot control it. That was the hard-nosed thread running through the ASI City Forum at Stanford on November 17: industrial AI is not just about smarter models or splashy chip announcements. It is about whether manufacturers will trust a system with proprietary operating data,...

Continue Reading
Disney Springs Hotel Rates Test Holiday Demand Depth

Updated Category News Views 192

A $145 room rate is the sort of holiday bait that gets my attention before the fake snow does. Disney Springs Resort Area Hotels are extending a seasonal offer for stays through Dec. 18, 2026, with bookings open only through Nov. 20. That is a very narrow selling window, and it tells you plenty: these seven independent hotels want to fill rooms during a lucrative but...

Continue Reading
LiberNovo's Black Friday Chair Sale Tests Premium Demand

Updated Category News Views 62

Ergonomic chairs are not impulse purchases, and LiberNovo knows it. Its Black Friday push in the United States and Canada runs through November 30, throwing discounts, gifts, prize-wheel entries and loyalty points at buyers considering a fairly expensive piece of office equipment. That is a lot of promotional machinery for a chair sale, but the underlying pitch is...

Continue Reading
Rescue Dog Wines Puts Holiday Bottles to Work for Dogs

Updated Category News Views 74

A Bottle With a Job Beyond the Table Holiday wine promotions usually arrive wrapped in the same tired ribbon: buy more, save a little, pour it at a party, forget it by January. Rescue Dog Wines is taking a more grounded route. The family-owned Lodi-area winery says it gives 50% of profits to animal rescue organizations, and that commitment is not being dressed up as a...

Continue Reading
Pacific Surfliner Faces Thanksgiving Capacity Test

Updated Category News Views 122

Thanksgiving traffic on Southern California freeways is its own yearly punishment, and the Pacific Surfliner is making a sensible pitch: leave the car parked and let the coast roll past the window. For travelers, that can be a real relief. For anyone watching public transportation, this is also a useful little stress test of whether a busy state-supported rail corridor...

Continue Reading

Top 5 Most Recently Viewed Articles

Legit Security Named as a Top Performer in Application Security

Updated Category News Views 210

Legit Security Recognized as a Leader in Application Security Legit Security, a leader in AI-native Application Security Posture Management (ASPM), has recently been acknowledged as a prominent player in the IDC MarketScape for ASPM. This achievement reflects the company's commitment to securing AI-powered application development processes. The IDC MarketScape report...

Continue Reading
Active Dental Transforms Patient Experience with New Website

Updated Category News Views 140

Active Dental Enhances Patient Accessibility with Unified Website Active Dental, a reputable family and general dentistry practice in the Dallas-Fort Worth metroplex, has launched a newly redesigned website that seamlessly integrates all five of its practice locations into a single, user-friendly digital platform. This significant upgrade aims to make appointment...

Continue Reading
Stork Club's Innovative Approach to Postpartum Depression Support

Updated Category News Views 229

Stork Club Innovates Reproductive Health Care Stork Club has recently launched an unprecedented initiative aimed at addressing postpartum depression (PPD) among working mothers. This pioneering program offers a seamless blend of digital diagnostics and therapy, leading to significant improvements in mental health outcomes. With up to 20% immediate relief from PPD symptoms...

Continue Reading
Investors Eye Class Action Against Fortrea Holdings, Inc.

Updated Category News Views 114

Understanding the Fortrea Holdings, Inc. Class Action Fortrea Holdings, Inc. (NASDAQ: FTRE) has gained attention due to rising investor concerns regarding its recent financial disclosures. Investors who have experienced losses over $100,000 are now presented with an opportunity to potentially lead a securities fraud lawsuit against the company. This lawsuit highlights...

Continue Reading
Alpha Tau Medical Plans Engagements at Key Healthcare Events

Updated Category News Views 91

Upcoming Participation in Major Healthcare Conferences Alpha Tau Medical Ltd., a leading developer of innovative cancer therapies, is gearing up for an exciting presence at significant healthcare conferences. The involvement of the Chief Financial Officer, Raphi Levy, at these events marks a pivotal opportunity for the company to showcase its groundbreaking...

Continue Reading